Genmab — Februar 2020
-
Ok så. Go' morgen transalp
-
og til alle andre naturligvis.
-
-
Ugens aktie: Skal Genmab være Danmarks Google?
Genmab, der blevet stiftet for 21 år siden, har haft fantastisk succes, og selvtilliden rækker i dag til en ambition om at transformere behandlingen af kræft, så patienterne løbende må tage medicin, men vil leve godt – ligesom f.eks. diabetikere gør det. Om et par uger ventes nye meldinger om selskabets kliniske forsøg.
Finans (finans.dk)
-
Tak E L. Nogen der har adgang til finans.dk, som kan gengive et par hovedpunkter?
-
The DuoBody Mim-8 (Novo Nordisk) has started recruiting https://clinicaltrials.gov/ct2/show/NCT04204408?term=Lu+AF82422+OR+HuMax-IL-8+OR+BMS-986253+OR+Novo+Nordisk+MIM-8&lupd_s=02%2F06%2F2020&lupd_e=02%2F10%2F2020&draw=2&rank=1
-
Det vil bår' vær særlig...
-
dæjlig..:-)
-
-
Janssen Announces Submission to U.S. FDA for New DARZALEX
(Daratumumab)-BasedCombination RegimenforPatients with Relapsed/Refractory Multiple Myeloma https://www.janssen.com/us/sites/www_janssen_com_usa/files/darzalex_candor_fda_filing.pdf -
God morgen.
-
Tak Svinnius.
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind